IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

266.90 4.14 −1.53%
Market cap
$44.6B
P/E
32.8×
Fwd P/E
22.3×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

25.84 28.43 20.95 23.77
P/S ratio
2.03 2.38 1.73 1.89
P/FCF ratio
14.14 18.23 13.11 14.21
P/Operating CF
35.60 52.72 46.47 57.52
P/B ratio
5.14 5.84 4.52 5.09
EV/Sales
2.85 3.21 2.55 2.71
EV/EBITDA
13.60 15.63 12.52 13.51
EV/FCF
19.82 24.61 19.37 20.37
Current Ratio
0.70 0.75 0.75 0.71
Net Debt/EBITDA
15.37 14.30 16.99 17.31
Debt/Equity
2.38 2.37 2.49 2.54
Earnings Yield
3.87% 3.52% 4.77% 4.21%
Free Cash Flow Yield
7.07% 5.49% 7.63% 7.04%
Free Cash Flow per Share
4.98 3.26 2.92 2.17
Book value per Share
36.94 38.57 37.70 37.94
Free Cash Flow
847.00 561.00 491.00 360.00
EV/EBIT
20.78 23.98 19.30 20.91
Other line items

Show all line items

Columns are period end dates